HCV Replication Complex Inhibitors
- Name
- HCV Replication Complex Inhibitors
- Accession Number
- DBCAT003783
- Description
Not Available
- Drugs
Drug Drug Description Daclatasvir A direct-acting antiviral agent used to treat specific hepatitis C virus (HCV) infections in combination with other antiviral agents. - Drugs & Drug Targets